Publicaciones en colaboración con investigadores/as de Hospital Virgen del Camino (41)

2024

  1. Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register

    RMD open, Vol. 10, Núm. 1

  2. SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

    Lupus Science and Medicine, Vol. 11, Núm. 1

2023

  1. Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients

    Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 829-836

  2. The complex HLA-E-nonapeptide in Behçet disease

    Frontiers in Immunology, Vol. 14

2022

  1. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

    npj Genomic Medicine, Vol. 7, Núm. 1

  2. Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients

    Therapeutic Advances in Musculoskeletal Disease, Vol. 14

2021

  1. Novel germinal mutation in NF1: case report

    Molecular Biology Reports, Vol. 48, Núm. 11, pp. 7617-7620

  2. Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review

    Therapeutic Advances in Musculoskeletal Disease, Vol. 13

  3. Validation of diagnostic codes and epidemiologic trends of Huntington disease: a population-based study in Navarre, Spain

    Orphanet Journal of Rare Diseases, Vol. 16, Núm. 1

2020

  1. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

    Scientific Reports, Vol. 10, Núm. 1

  2. Fracture risk assessment in the general population in Spain by FRAX® algorithm. EPISER2016 study

    Medicina Clinica, Vol. 154, Núm. 5, pp. 163-170

2019

  1. Association of Functional Polymorphisms of KIR3DL1/DS1 With Behçet's Disease

    Frontiers in Immunology, Vol. 10

  2. Behçet’s disease and genetic interactions between HLA-B*51 and variants in genes of autoinflammatory syndromes

    Scientific Reports, Vol. 9, Núm. 1

  3. Epidemiological study and genetic characterization of inherited muscle diseases in a northern Spanish region

    Orphanet Journal of Rare Diseases, Vol. 14, Núm. 1

  4. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

  5. Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims and methodology

    Reumatologia Clinica, Vol. 15, Núm. 2, pp. 90-96

2017

  1. A reduced 12-joint ultrasound examination predicts lack of X-ray progression better than clinical remission criteria in patients with rheumatoid arthritis

    Rheumatology International, Vol. 37, Núm. 8, pp. 1347-1356

  2. Mutational profile of rare variants in inflammasome-related genes in Behçet disease: A Next Generation Sequencing approach

    Scientific Reports, Vol. 7, Núm. 1

  3. Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach

    PLoS ONE, Vol. 12, Núm. 9

2016

  1. Genetic analysis with the immunochip platform in Behçet disease. Identification of residues associated in the HLA class I region and new susceptibility loci

    PLoS ONE, Vol. 11, Núm. 8